Ferozsons LaboratoriesKAR:FEROZ -0.17%76 Operating Margin % is 8.50% as of Mar. 2026, which is 16% below its 10-year median of 10.10. GuruFocus rates KAR:FEROZ with a GF Score™ of 76/100 and a GF Value™ of ₨418.18 (Fairly Valued). The stock has 5 warning signs investors should review. Among 956 Drug Manufacturers companies, Ferozsons Laboratories ranks better than 55.33% on this metric.
Ferozsons Laboratories Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -3%.
The historical rank and industry rank for Ferozsons Laboratories's Operating Margin % or its related term are showing as below:
KAR:FEROZ'
s Operating Margin % Range Over the Past 10 Years
Min: -0.05 Med: 10.1 Max: 24.92
Current: 10.11
KAR:FEROZ's Operating Margin % is ranked better than 55.33% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs KAR:FEROZ: 10.11
Ferozsons Laboratories's 5-Year Average Operating Margin % Growth Rate was -3.00% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Ferozsons Laboratories Operating Margin % Related Terms
Ferozsons Laboratories Operating Margin % Historical Data
* Premium members only.
The historical data trend for Ferozsons Laboratories's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAR:FEROZ vs ZTS, UTHR, VTRS: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ferozsons Laboratories Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Ferozsons Laboratories's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Ferozsons Laboratories's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ferozsons Laboratories (KAR:FEROZ) has a Operating Margin % of 8.50% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Ferozsons Laboratories and its competitors. This is 16% below median its historical median of 10.10. According to the industry distribution chart, Ferozsons Laboratories ranks #427 out of 956 companies in the Drug Manufacturers industry, placing it in the top 44.7%.
Is Ferozsons Laboratories' Operating Margin % too high?
Ferozsons Laboratories' current Operating Margin % of 8.50% is 16% below median its 10-year median of 10.10. The Drug Manufacturers industry median Operating Margin % is 7.58. Ferozsons Laboratories' value of 8.50% is 12.1% above this industry median. Based on the distribution chart, Ferozsons Laboratories ranks #427 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ferozsons Laboratories has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ferozsons Laboratories ranks #427 out of 956 companies for Operating Margin %. This puts Ferozsons Laboratories in the upper half of its industry. The industry median Operating Margin % is 7.58. Ferozsons Laboratories' value of 8.50% is 12.1% above this benchmark. While the company's 10-year median is 10.10 vs. the industry median of 7.58, Ferozsons Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ferozsons Laboratories's current Operating Margin % of 8.50% is 12.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Ferozsons Laboratories and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ferozsons Laboratories's current Operating Margin % is 8.50%, which is 16% below median its own 10-year median of 10.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Fairly Valued. The stock's GF Value™ is ₨418.18, compared to a current price of ₨411.15 — trading 1.7% below its estimated fair value. The current Operating Margin % is 8.50%, which is 16% below median its 10-year median of 10.10 and 12.1% above the Drug Manufacturers industry median of 7.58. Ferozsons Laboratories' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Operating Margin % is 8.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?
Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued.
The current stock price of ₨411.15 is trading 1.7% below its estimated GF Value™ of ₨418.18.
GuruFocus considers Ferozsons Laboratories to be Fairly Valued.
Key valuation signals for KAR:FEROZ:
Operating Margin %: 8.50% (16% below median its 10-year median of 10.10)
GF Value™: ₨418.18 vs. price of ₨411.15 (1.7% below fair value)
Industry Position: 12.1% above the Drug Manufacturers median (#427 of 956)
No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
76GF Score
Get the complete analysis for KAR:FEROZ
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:FEROZ has been successfully added to your 
